---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-028099"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T02:29:18.451468+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q4 revenue $325.5M (+16% YoY); 2025 EBITDA guidance $130-150M

## Summary
- Q4 revenue $325.5M (+16% YoY); full year $1.251B (+19% YoY).
- Net loss narrowed to $7.1M in Q4 vs $45.0M prior; full year $57.4M vs $186.3M.
- Adjusted EBITDA Q4 $32.8M (+62% YoY); full year $119.7M (+103% YoY).
- 2025 guidance: revenue $1.40B-$1.44B, Center Margin $440M-$464M, Adj. EBITDA $130M-$150M.
- Free cash flow $85.7M for 2024; cash $154.6M, net long-term debt $279.8M.

## SEC filing metadata
- accession: 0000950170-25-028099
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/0000950170-25-028099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/lfst-20250227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-028099
- JSON: https://secwatch.observer/filing/0000950170-25-028099.json
- Plain text: https://secwatch.observer/filing/0000950170-25-028099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.